Literature DB >> 3124728

Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

R Pujadas1, E Escriva, J Jane, M C Galera, P Fava, J Garau, B Mirelis.   

Abstract

Four oral penicillin V regimens were compared for the ability to prevent Streptococcus sanguis infection of experimentally induced valvular heart lesions in rabbits. Challenge doses of 10(4), 10(6), and 10(8) CFU of a penicillin-susceptible strain of S. sanguis were used in this study. Measured by recovery of test organisms from endocardial lesions, the lowest-concentration inoculum was infective for 53% of the recipients; the higher-concentration inocula were infective for all recipients. A single-oral-dose penicillin V regimen (36 mg/kg of body weight) prevented endocarditis when rabbits were challenged with 10(4) CFU, but protection diminished with increasing inoculum concentrations. In contrast, addition of a second penicillin V dose (18 mg/kg of body weight) administered with a 7-h interval between doses achieved fully effective prophylaxis against even the highest inoculum tested (10(8) CFU). A repeated set of experiments in which half the dose of penicillin V was administered showed significantly reduced protection against S. sanguis endocarditis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124728      PMCID: PMC174974          DOI: 10.1128/AAC.31.10.1474

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia.

Authors:  D C Shanson; P Cannon; M Wilks
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

2.  Comparative capacity of orally administered amoxicillin and parenterally administered penicillin-streptomycin to protect rabbits against experimentally induced streptococcal endocarditis.

Authors:  R Pujadas; E Escriva; J Jane; F Fernandez; P Fava; J Garau
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  Significance of penicillin tolerance in vivo: prevention of experimental Streptococcus sanguis endocarditis.

Authors:  J Hess; J Dankert; D Durack
Journal:  J Antimicrob Chemother       Date:  1983-06       Impact factor: 5.790

6.  Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics.

Authors:  M P Glauser; P Francioli
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

7.  Penicillin-sensitive streptococcal endocarditis. In-vitro and clinical observations on penicillin-streptomycin therapy.

Authors:  J C Wolfe; W D Johnson
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

8.  Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing.

Authors:  J P Bernard; P Francioli; M P Glauser
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection.

Authors:  M P Glauser; J P Bernard; P Moreillon; P Francioli
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

10.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
View more
  1 in total

1.  Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

Authors:  R Pujadas; E Escriva; J Jane; J Argimon; F Fernandez; P Fava; M Galera; J Garau
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.